- Home
- DSS vs CARM Comparison
DSS vs CARM Comparison
Compare DSS & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSS
- CARM
- Stock Information
- Founded
- DSS 1984
- CARM 2016
- Country
- DSS United States
- CARM United States
- Employees
- DSS N/A
- CARM N/A
- Industry
- DSS Containers/Packaging
- CARM Biotechnology: Pharmaceutical Preparations
- Sector
- DSS Consumer Discretionary
- CARM Health Care
- Exchange
- DSS Nasdaq
- CARM Nasdaq
- Market Cap
- DSS 8.1M
- CARM 7.7M
- IPO Year
- DSS N/A
- CARM N/A
- Fundamental
- Price
- DSS $0.85
- CARM $0.19
- Analyst Decision
- DSS
- CARM Hold
- Analyst Count
- DSS 0
- CARM 5
- Target Price
- DSS N/A
- CARM $0.90
- AVG Volume (30 Days)
- DSS 13.6K
- CARM 911.1K
- Earning Date
- DSS 05-15-2025
- CARM 05-13-2025
- Dividend Yield
- DSS N/A
- CARM N/A
- EPS Growth
- DSS N/A
- CARM N/A
- EPS
- DSS N/A
- CARM N/A
- Revenue
- DSS $20,180,000.00
- CARM $19,964,000.00
- Revenue This Year
- DSS N/A
- CARM N/A
- Revenue Next Year
- DSS N/A
- CARM N/A
- P/E Ratio
- DSS N/A
- CARM N/A
- Revenue Growth
- DSS 12.88
- CARM 32.45
- 52 Week Low
- DSS $0.72
- CARM $0.14
- 52 Week High
- DSS $1.90
- CARM $1.90
- Technical
- Relative Strength Index (RSI)
- DSS 43.41
- CARM 48.12
- Support Level
- DSS $0.79
- CARM $0.17
- Resistance Level
- DSS $0.89
- CARM $0.21
- Average True Range (ATR)
- DSS 0.06
- CARM 0.02
- MACD
- DSS -0.01
- CARM 0.00
- Stochastic Oscillator
- DSS 63.77
- CARM 66.44
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.